Advertisement

Table of Contents

January 01, 1986; Volume 29,Issue 1

You have access
Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
H J Motulsky, S J Shattil, N Ferry, D Rozansky and P A Insel

Molecular Pharmacology January 1986, 29 (1) 1-6;
You have access
Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
L C Mahan and P A Insel

Molecular Pharmacology January 1986, 29 (1) 7-15;
You have access
Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
L C Mahan and P A Insel

Molecular Pharmacology January 1986, 29 (1) 16-22;
You have access
Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
M Laburthe, A Couvineau and C Rouyer-Fessard

Molecular Pharmacology January 1986, 29 (1) 23-27;
You have access
Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.
H Weinstein, A P Mazurek, R Osman and S Topiol

Molecular Pharmacology January 1986, 29 (1) 28-33;
You have access
Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
M A Cascieri, G G Chicchi, R M Freidinger, C D Colton, D S Perlow, B Williams, N R Curtis, A T McKnight, J J Maguire and D F Veber

Molecular Pharmacology January 1986, 29 (1) 34-38;
You have access
Evidence for the existence of high affinity binding sites for indomethacin on human blood platelets.
R Magous, J P Bali, R Escale, J P Girard, E Rechencq and J C Rossi

Molecular Pharmacology January 1986, 29 (1) 39-44;
You have access
Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices.
R S Jope and G V Johnson

Molecular Pharmacology January 1986, 29 (1) 45-51;
You have access
The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex.
F Henderson, C Prior, J Dempster and I G Marshall

Molecular Pharmacology January 1986, 29 (1) 52-64;
You have access
Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
P M Matthews, D Foxall, L Shen and T E Mansour

Molecular Pharmacology January 1986, 29 (1) 65-73;
You have access
The interaction of the beta-anomer of doxorubicin with B and Z DNA.
M Britt, F Zunino and J B Chaires

Molecular Pharmacology January 1986, 29 (1) 74-80;
You have access
Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
T R Tephly, K A Black, M D Green, B L Coffman, G A Dannan and F P Guengerich

Molecular Pharmacology January 1986, 29 (1) 81-87;
You have access
A new method to study glutathione adduct formation in periportal and pericentral regions of the liver lobule by micro-reflectance spectrophotometry.
C Harris and R G Thurman

Molecular Pharmacology January 1986, 29 (1) 88-96;
You have access
Cysteine conjugate beta-lyase in the gastrointestinal bacterium Eubacterium limosum.
G L Larsen and J L Stevens

Molecular Pharmacology January 1986, 29 (1) 97-103;
You have access
Regulation of protein synthesis in isolated hepatocytes by calcium-mobilizing hormones.
C O Brostrom, S B Bocckino, M A Brostrom and E M Galuska

Molecular Pharmacology January 1986, 29 (1) 104-111;